Policymakers would be wise to let the ACA fully develop before making substantial changes

A look at the crisis in 10 charts

Understanding a global health crisis from the confines of home

It’s time to talk about updating the HRBC formula to reflect the nature of the risks facing today’s health insurers

Actuarial expertise is informing clinical decision-making and health care cost-impact modeling

Initiative 18|11 explores prescription drug rebates and their impact on consumer pharmacy spend

Actuaries should account for the impact of coupons and PAPs on the health care system

Health actuaries should consider DTCPA impact when developing cost projections and setting premium rates

Measuring and understanding cost trends will be essential to addressing increasing pharmaceutical costs

A brief history of ERM modeling and what’s coming next